Publication: ESMO BREAST CANCER CONGRESS 2022 Authors Esther Schuler(1), Read More
Annals of Oncology, Volume 33, Issue 3, March 2022, Pages 310-320 Authors: Lopes Cardozo et al.
Read MoreJournal of Clinical Oncology, Volume 40, Number 12, January 21, 2022 Authors: Audeh et al.
Read MoreI-SPY2 Trial, Cancer Cell 39, 989โ998, 2021 Authors: Pusztai et al.
Read MorePUBLICATION: ASCO 2021 ย Authors Joyce OโShaughnessy1, Virginia G. Read More
PUBLICATION: ASCO 2021 ย Authors Cathy Graham1, Douglas K. Read More
PUBLICATION: ASCO 2021 Authors Nina DโAbreo1,2, Abhinav Rohatgi1,2, Douglas Read More
NSABP B-42 Trial, ASCO 2021 Abstract #502 Authors: Rastogi, et al.
Read Moreย Publication: St. Gallen Authors: Jennifer A. Crozier, Lisa Blumencranz, Read More
Publication: St. Gallen Authors: E. Gรถker, M.P. Hendriks, M. van Read More
Contact
For the US, Puerto Rico, Canada
and South America
Agendia Inc. USA, 22 Morgan, Irvine, CA 92618
(888) 321-2732
customercare@agendia.com
For outside the Americas
Agendia NV, Radarweg 60, 1043 NT Amsterdam, The Netherlands
+31 (0)20 462 1510
customerservice@agendia.com
ยฉ2025 Agendia. All rights reserved. MammaPrint and Blueprint are registered trademarks of Agendia, Inc.
CHIEF COMPLIANCE OFFICER
Stephanie has worked in compliance since 2005 and has extensive experience developing and managing programs to support compliance with global, federal, and state laws and regulations in the healthcare and biotech industries. Prior to joining Agendia, Stephanie spent a significant portion of her career serving as a compliance officer in laboratories, such as HealthTrackRx, NeoGenomics, and Myriad Genetics, and held compliance leadership roles in medical device, pharma, and large health systems.
Stephanie graduated Summa Cum Laude with a B.S. in Healthcare Administration from Northern Illinois University and is Certified in Healthcare Compliance (CHC), Data Privacy (CHP), Research Compliance (CHRC), and is a Certified Internal Auditor (CIA).
